95 related articles for article (PubMed ID: 22214424)
1. Improving care for patients with type 2 diabetes: applying management guidelines and algorithms, and a review of new evidence for incretin agents and lifestyle intervention.
Blonde L
Am J Manag Care; 2011 Nov; 17 Suppl 14():S368-76. PubMed ID: 22214424
[TBL] [Abstract][Full Text] [Related]
2. Advances in the treatment of type 2 diabetes mellitus.
Israili ZH
Am J Ther; 2011; 18(2):117-52. PubMed ID: 19834322
[TBL] [Abstract][Full Text] [Related]
3. Update on type 2 diabetes mellitus: understanding changes in the diabetes treatment paradigm.
Green J; Feinglos M
Int J Clin Pract Suppl; 2007 Aug; (154):3-11. PubMed ID: 17593272
[TBL] [Abstract][Full Text] [Related]
4. Diabetes and obesity: therapeutic targeting and risk reduction - a complex interplay.
Niswender K
Diabetes Obes Metab; 2010 Apr; 12(4):267-87. PubMed ID: 20380648
[TBL] [Abstract][Full Text] [Related]
5. Incretin-based therapy in chronic kidney disease.
Pinelli NR; Moore CL; Tomasello S
Adv Chronic Kidney Dis; 2010 Sep; 17(5):439-49. PubMed ID: 20727514
[TBL] [Abstract][Full Text] [Related]
6. DPP-4 inhibitors and GLP-1 analogues: for whom? Which place for incretins in the management of type 2 diabetic patients?
Halimi S
Diabetes Metab; 2008 Feb; 34 Suppl 2():S91-5. PubMed ID: 18640591
[TBL] [Abstract][Full Text] [Related]
7. Type 2 diabetes mellitus: practical approaches for primary care physicians.
Gavin JR; Freeman JS; Shubrook JH; Lavernia F
J Am Osteopath Assoc; 2011 May; 111(5 Suppl 4):S3-12; quiz S13. PubMed ID: 21697547
[TBL] [Abstract][Full Text] [Related]
8. In support of an early polypharmacy approach to the treatment of type 2 diabetes.
Wright EE; Stonehouse AH; Cuddihy RM
Diabetes Obes Metab; 2010 Nov; 12(11):929-40. PubMed ID: 20880339
[TBL] [Abstract][Full Text] [Related]
9. Loss of confidence in diabetes management.
Salber PR; Bestermann W; Schwartz S; Marchetti A
Manag Care; 2008 Oct; 17(10):38-46. PubMed ID: 18990924
[TBL] [Abstract][Full Text] [Related]
10. State of diabetes care in the United States.
Blonde L
Am J Manag Care; 2007 Apr; 13 Suppl 2():S36-40. PubMed ID: 17417931
[TBL] [Abstract][Full Text] [Related]
11. The changing landscape of type 2 diabetes: the role of incretin-based therapies in managed care outcomes.
Triplitt C; McGill JB; Porte D; Conner CS
J Manag Care Pharm; 2007 Dec; 13(9 Suppl C):S2-16; quiz S17. PubMed ID: 18062735
[TBL] [Abstract][Full Text] [Related]
12. New treatments in type 2 diabetes: a focus on the incretin-based therapies.
Barnett AH
Clin Endocrinol (Oxf); 2009 Mar; 70(3):343-53. PubMed ID: 18771570
[TBL] [Abstract][Full Text] [Related]
13. Antihyperglycaemic therapy in elderly patients with type 2 diabetes: potential role of incretin mimetics and DPP-4 inhibitors.
Mathieu C; Bollaerts K
Int J Clin Pract Suppl; 2007 Aug; (154):29-37. PubMed ID: 17593275
[TBL] [Abstract][Full Text] [Related]
14. Antidiabetic medications in overweight/obese patients with type 2 diabetes: drawbacks of current drugs and potential advantages of incretin-based treatment on body weight.
Bonora E
Int J Clin Pract Suppl; 2007 Aug; (154):19-28. PubMed ID: 17593274
[TBL] [Abstract][Full Text] [Related]
15. Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes.
Jones MR; Mudaliar S; Hernandez-Triana E; Unnikrishnan AG; Lai YL; Abby SL; Misir S; Jin X; Nagendran S
Curr Med Res Opin; 2009 Sep; 25(9):2239-49. PubMed ID: 19622007
[TBL] [Abstract][Full Text] [Related]
16. Incretin based therapies for type 2 diabetes mellitus.
Ghosh S; Collier A; Elhadd T; Malik I
J Indian Med Assoc; 2008 Jun; 106(6):373-4, 383, 388. PubMed ID: 18839649
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacology of incretin therapies for type 2 diabetes mellitus: implications for treatment.
Neumiller JJ
Clin Ther; 2011 May; 33(5):528-76. PubMed ID: 21665041
[TBL] [Abstract][Full Text] [Related]
18. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
[TBL] [Abstract][Full Text] [Related]
19. The physiologic role of incretin hormones: clinical applications.
Cefalu WT
J Am Osteopath Assoc; 2010 Mar; 110(3 Suppl 2):S8-S14. PubMed ID: 20382839
[TBL] [Abstract][Full Text] [Related]
20. Time to insulin in type-2 diabetes: high hurdles or Santiago way?
Rotella CM; Pala L
Acta Diabetol; 2008 Jun; 45(2):67-74. PubMed ID: 18408882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
